The effect of ITPa polymorphisms on the enzyme kinetic properties of human erythrocyte inosine triphosphatase toward its substrates ITP and 6-thio-ITP

Nucleosides, Nucleotides and Nucleic Acids

Volumn 30, Issue 11, 2011, Pages 839-849

  Bakker, Jaap A ^a   Lindhout, Martijn ^a   Habets, Daphna D J ^a   Van Den Wijngaard, Arthur ^a   Paulussen, Aimee D C ^a   Bierau, Jörgen ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adverse drug reactions; ITPase; Pharmaco genetics; Substrate specificity; Thiopurines

Indexed keywords

INOSINE TRIPHOSPHATE; MERCAPTOPURINE; PHOSPHATASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME SUBSTRATE; ERYTHROCYTE; HUMAN; HUMAN CELL;

ERYTHROCYTES; HUMANS; INOSINE TRIPHOSPHATE; POLYMORPHISM, GENETIC; POLYPHOSPHATES; PYROPHOSPHATASES; SUBSTRATE SPECIFICITY; THIOINOSINE;

EID: 84855884329     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770.2011.606789     Document Type: Article

References (25)

1. Galperin, M. Y.; Moroz, O. V.; Wilson, K. S.; Murzin, A. G. House cleaning, a part of good housekeeping. Mol. Microbiol. 2006, 59, 5-19.
2. Bierau, J.; Lindhout, M.; Bakker, J. A. Pharmacogenetic significance of inosine triphosphatase. Pharmacogenomics 2007, 8, 1221-1228. (Pubitemid 47578231)
3. Vanderheiden, B. S. Human erythrocyte "ITPase": an ITP pyrophosphohydrolase. Biochim. Biophys. Acta 1970, 215, 555-558.
4. Duley, J. A.; Simmonds, H. A.; Hopkinson, D. A.; Levinsky, R. J. Inosine triphosphate pyrophosphohydrolase deficiency in a kindred with adenosine deaminase deficiency. Clin. Chim. Acta 1990, 188, 243-252. (Pubitemid 20176149)
5. Behmanesh, M.; Sakumi, K.; Abolhassani, N.; Toyokuni, S.; Oka, S.; Ohnishi, Y. N.; et al. ITPasedeficient mice show growth retardation and die before weaning. Cell Death Differ. 2009, 16, 1315-1322.
6. Abolhassani, N.; Iyama, T.; Tsuchimoto, D.; Sakumi, K.; Ohno, M.; Behmanesh, M.; et al. NUDT16 and ITPA play a dual protective role in maintaining chromosome stability and cell growth by eliminating dIDP/IDP and dITP/ITP from nucleotide pools in mammals. Nucleic Acids Res. 2010, 38, 2891-2903.
7. Fellay, J.; Thompson, A. J.; Ge, D.; Gumbs, C. E.; Urban, T. J.; Shianna, K. V.; et al. ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C. Nature 2010, 464, 405-408.
8. Hitomi, Y.; Cirulli, E. T.; Fellay, J.; McHutchison, J. G.; Thompson, A. J.; Gumbs, C. E.; et al. Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by restoring adenylosuccinate synthase function. Gastroenterology 2011, 140, 1314-1321.
9. Marinaki, A. M.; Ansari, A.; Duley, J. A.; Arenas, M.; Sumi, S.; Lewis, C. M.; et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 2004, 14, 181-187. (Pubitemid 38373112)
10. Ansari, A.; Arenas, M.; Greenfield, S. M.; Morris, D.; Lindsay, J.; Gilshenan, K.; et al. Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease. Aliment. Pharmacol. Ther. 2008; 28, 973-983.
11. Zelinkova, Z.; Derijks, L. J.; Stokkers, P. C.; Vogels, E. W.; van Kampen, A. H.; Curvers, W. L.; et al. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Clin. Gastroenterol. Hepatol. 2006, 4, 44-49. (Pubitemid 43129523)
12. Hawwa, A. F.; Millership, J. S.; Collier, P. S.; Vandenbroeck, K.; McCarthy, A.; Dempsey, S.; et al. Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine. Br. J. Clin. Pharmacol. 2008, 66, 517-528.
13. De Ridder, L.; van Dieren, J. M.; van Deventer, H. J.; Stokkers, P. C.; van der Woude, J. C.; van Vuuren, A. J.; et al. Pharmacogenetics of thiopurine therapy in paediatric IBD patients. Aliment. Pharmacol. Ther. 2006, 23, 1137-1141. (Pubitemid 43779353)
14. Kurzawski, M.; Dziewanowski, K.; Lener, A.; Drozdzik, M. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients. Eur. J. Clin. Pharmacol. 2009, 65, 533-540.
15. van Dieren, J. M.; van Vuuren, A. J.; Kusters, J. G.; Nieuwenhuis, E. E.; Kuipers, E. J.; van der Woude, C. J. ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients. Gut 2005, 54, 1664. (Pubitemid 41531793)
16. Hindorf, U.; Lindqvist, M.; Peterson, C.; Soderkvist, P.; Strom, M.; Hjortswang, H.; et al. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease. Gut 2006, 55, 1423-1431. (Pubitemid 44476786)
17. van Dieren, J. M.; Hansen, B. E.; Kuipers, E. J.; Nieuwenhuis, E. E.; van der Woude, C. J. Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease. Aliment. Pharmacol. Ther. 2007, 26, 643-652. (Pubitemid 47246201)
18. Herting, G.; Barber, K.; Zappala, M. R.; Cunningham, R. P.; Burgis, N. E. Quantitative in vitro and in vivo characterization of the human P32T mutant ITPase. Biochim. Biophys. Acta. 2010, 1802, 269-274.
19. Stepchenkova, E. I.; Tarakhovskaya, E. R.; Spitler, K.; Frahm, C.; Menezes, M. R.; Simone, P. D.; et al. Functional study of the P32T ITPA variant associated with drug sensitivity in humans. J. Mol. Biol. 2009; 392, 602-613.
20. Stenmark, P.; Kursula, P.; Flodin, S.; Graslund, S.; Landry, R.; Nordlund, P.; et al. Crystal structure of human inosine triphosphatase: Substrate binding and implication of the inosine triphosphatase deficiency mutation P32T. J. Biol. Chem. 2007, 282, 3182-3187. (Pubitemid 47084319)
21. Shipkova, M.; Lorenz, K.; Oellerich, M.; Wieland, E.; von Ahsen, N. Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotypephenotype in a Caucasian population. Clin. Chem. 2006, 52, 240-247. (Pubitemid 43185485)
22. Arenas, M.; Duley, J.; Sumi, S.; Sanderson, S. The ITPA c.94C>A and g. IVS2+21A>C sequence variants contribute to missplicing of the ITPA gene. Biochem. Biophys. Acta 2007, 1772, 96-102. (Pubitemid 44960729)
23. Poppe, B.; Vandesompele, J.; Schoch, C.; Lindvall, C.; Mrozek, K.; Bloomfield, C. D.; et al. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 2004, 103, 229-235. (Pubitemid 38029943)
24. Bierau, J.; Bakker, J. A.; Lindhout, M.; van Gennip, A. H. Determination of ITPase activity in erythrocyte lysates obtained for determination of TPMT activity. Nucleos. Nucleot. Nucl. Acids 2006, 25, 1129-1132. (Pubitemid 44651860)
25. Sumi, S.; Marinaki, A. M.; Arenas, M.; Fairbanks, L.; Shobowale-Bakre, M.; Rees, D. C.; et al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum. Genet. 2002; 111, 360-367. (Pubitemid 36075062)